Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Priya K Patel"'
Publikováno v:
Cureus.
Autor:
R. R. Shah, Priya K. Patel
Publikováno v:
Molecular Crystals and Liquid Crystals. 643:168-177
A meta substituted chalconyl ester homologous series: RO‒C6H4‒COO‒C6H4(meta)‒CO‒CH˭CH‒C6H4‒OC12H25(n)(para) is synthesized and studied with a view to understanding the effect of molecular substitut...
Autor:
Priya K. Patel, R. R. Shah
Publikováno v:
Molecular Crystals and Liquid Crystals. 641:1-9
A novel liquid crystalline homologous series of chalconyl vinyl esters with a lateral bromo substituent RO─C6H4─CH═CH─COO─C6H3─(Br)─CO-CH═CH─C6H4─C12H25(n) has been synthesized and studied with a v...
Autor:
Priya K. Patel, R. R. Shah
Publikováno v:
Molecular Crystals and Liquid Crystals. 637:37-46
A novel nonlinear homologous series RO‒C6H4‒CH˭CH‒COO‒C6H4 (meta) ‒CO‒CH˭CH‒C6H4‒OC12H25(n) (para) consisting of three phenyl rings, two central bridges ‒CH˭CH‒COO‒ and ‒CO‒CH˭CH‒ as well as ‒OR an...
Autor:
R. R. Shah, Priya K. Patel
Publikováno v:
Molecular Crystals and Liquid Crystals. 634:41-49
A novel thermotropically mesomorphic, meta-substituted nitro group of chalconyl ester series, RO-C6H4-COO-C6H3-(NO2)-CO-CH=CH-C6H4OC12H25(n) (para) is synthesized and studied with an aim to establish the relation between molecular structure and the m
Autor:
Priya K. Patel, R. R. Shah
Publikováno v:
Molecular Crystals and Liquid Crystals. 630:130-138
A novel homologous series RO-C6H4-COO-C6H4-CO-CH:CH-C6H4-OC12H25 of chalcones have been synthesized and studied with a view to understand and establish the effects of molecular structure on liquid crystal (LC) properties of a substance. Liquid crysta
Publikováno v:
Molecular Crystals and Liquid Crystals. 625:137-145
Two ester homologous series of mesogens, viz., Methyl-p-(p′-n-alkoxy benzoyloxy) cinnamates (X) and Methyl-p-(p′-n-alkoxy cinnamoyloxy) cinnamates (Y) being structurally similar are discussed. Both...
Publikováno v:
Cureus
Atrial fibrillation is a heart arrhythmia associated with increased risk for ischemic stroke. Vitamin K antagonists were developed to decrease a patient's clotting risk; however, these medications require therapeutic monitoring and have several drug
Autor:
Priya K. Patel, Adalberto Torres
Publikováno v:
Pediatrics. 142:630-630